Stay updated on GSK2857916 Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.

Latest updates to the GSK2857916 Dose Escalation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe new screenshot mirrors the prior version, with only minor layout adjustments and no changes to core study details such as title, conditions, interventions, primary outcomes, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check20 days agoChange DetectedRelated topics updated to include Multiple Myeloma and MedlinePlus Genetics; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedCore page content updated to include a funding-status notice and operating-status guidance, plus a version upgrade from v3.1.0 to v3.2.0.SummaryDifference0.9%

- Check49 days agoChange Detected- Updated medical term from 'Plasma cell myeloma' to 'Multiple myeloma'. - Page revision bumped from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded a MedlinePlus Genetics topic covering multiple myeloma, expanding core medical content.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a new release tag v3.0.2 and removed the MedlinePlus Genetics topic on Multiple myeloma, along with the older revision note (v3.0.1) and the Back to Top link.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.